Autolus Therapeutics Plc logo

AUTL

Autolus Therapeutics Plc

$6.15

Earnings Summary

Revenue
$0.41Mn
Net Profits
$-45.85Mn
Net Profit Margins
-11292.86%

Highlights

Revenue:

Autolus Therapeutics Plc’s revenue fell -82.86% since last year same period to $0.41Mn in the Q3 2023. On a quarterly growth basis, Autolus Therapeutics Plc has generated +Inf% jump in its revenue since last 3-months.

Net Profits:

Autolus Therapeutics Plc’s net profit fell -7.21% since last year same period to $-45.85Mn in the Q3 2023. On a quarterly growth basis, Autolus Therapeutics Plc has generated -0.65% fall in its net profits since last 3-months.

Net Profit Margins:

Autolus Therapeutics Plc’s net profit margin fell -525.55% since last year same period to -11292.86% in the Q3 2023. On a quarterly growth basis, Autolus Therapeutics Plc has generated NaN% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Autolus Therapeutics Plc post its latest quarter earnings

EPS Estimate Current Quarter
-0.24
EPS Estimate Current Year
-0.24

Highlights

EPS Estimate Current Quarter:

Autolus Therapeutics Plc’s earning per share (EPS) estimates for the current quarter stand at -0.24 - a 6% jump from last quarter’s estimates.

EPS Estimate Current Year:

Autolus Therapeutics Plc’s earning per share (EPS) estimates for the current year stand at -0.24.

Key Ratios

Key ratios of the Autolus Therapeutics Plc post its Q3 2023 earnings

Earning Per Share (EPS)
-0.26

Highlights

Earning Per Share (EPS):

Autolus Therapeutics Plc’s earning per share (EPS) jumped 44.68% since last year same period to -0.26 in the Q3 2023. This indicates that the Autolus Therapeutics Plc has generated 44.68% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2023-08-03
-0.22
-0.26
-18.18%
2023-11-02
-0.25
-0.26
-4%
2023-05-04
-0.27
-0.23
14.81%